ZENARA's Generic Hydralazine HCL:Isosorbide Dinitrate Receives Approval in US
Enforcement Report - Week of February 19, 2020
Amneal Pharms 's Generic Frovatriptan Succinate Receives Approval in US
Glenmark Pharma has received the final nod from the US FDA to manufacture and market therapeutical equivalent of Endo Pharmaceutical's Frova tablets, used to treat migraine headaches, in the American market.
Glenmark`s Generic Frovatriptan Succinate approved in US to treat migraine